Clinical trials
Allergy clinical trials
Below are recruiting allergy clinical trials, each written for real people, not researchers. We’re tracking 323 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06916819Recruiting
Food allergy testing: at home or in clinic?
This study compares doing a food challenge at home versus in a medical clinic for people who think they might be allergic to a food. If you are over 18 and your skin test to that food is negative, you may be able to join.
Melbourne, VictoriaAges 18 years+ - NCT06919003RecruitingPhase 2
Improving kidney transplant with a single injection of a protective protein
This trial tests whether a single injection of C1 esterase inhibitor into a donated kidney during preservation can improve transplant outcomes. It is for adults on dialysis waiting for a deceased-donor kidney who meet specific blood and tissue matching requirements.
Los Angeles, CaliforniaAges 18–75 - NCT06934200RecruitingPhase 2
Xolair for food allergy in people with high IgE
This study tests if omalizumab (Xolair), an injectable medicine that blocks allergy antibodies, can help people with food allergies tolerate small amounts of their trigger foods. It's for people with high total IgE levels who were not eligible for a related study.
Baltimore, MarylandAges 1–55 - NCT06960382RecruitingPhase 1/Phase 2
Cat allergy immunotherapy with lymph node injections
This trial tests a new way to treat cat allergies by giving tiny injections directly into a lymph node (a part of your immune system), instead of under the skin. It aims to see if this method is safe and can reduce cat allergy symptoms, even in people with asthma.
ZurichAges 18–65 - NCT06971848Recruiting
Skin testing for biologic drug allergies
This trial checks if people can safely receive certain biologic drugs without allergic reactions, using skin tests to see how the body reacts. It may help find out if you are allergic to a biologic medicine you have taken before.
AngersAges 18 years+ - NCT06974877RecruitingPhase 1
PET/CT Imaging for Amyloid in CAPS on Anakinra
This trial uses a special PET/CT scan to see if a radioactive tracer can measure changes in amyloid buildup in people with CAPS who have developed a skin reaction to anakinra. It may help doctors understand how the disease is affecting your organs.
Bethesda, MarylandAges 18–120 - NCT06993103RecruitingPhase 4
Pasteurized donor milk for newborns of mothers with diabetes
This trial tests if giving pasteurized donor human milk to newborns of mothers with diabetes can help their health. It compares donor milk to regular baby formula as a supplement when extra feeding is needed soon after birth.
Brisbane, QueenslandAges birth–2 days - NCT07046806RecruitingPhase 1/Phase 2
Oral deucrictibant for hereditary angioedema attacks
This trial tests an oral medication called deucrictibant to prevent and treat swelling attacks in people with hereditary angioedema. It may help reduce the number and severity of attacks.
Wheaton, MarylandAges 18–75 - NCT07051902Recruiting
Microbiome and Atopy in Mali
This study is looking at how the natural bacteria on our skin and in our gut relate to eczema and asthma in people living in Mali. It will compare people with these conditions to healthy volunteers to learn more about what might cause them.
BamakoAges 3 years+ - NCT07055542Recruiting
New tool to predict thunderstorm asthma risk
This research study aims to create a simple tool to predict who is at risk for thunderstorm asthma. You will be asked to track your allergy symptoms and medications online during the spring, plus do a lung function test and give a blood sample.
Albury, New South WalesAges 18–70 - NCT07059091RecruitingPhase 2
Omalizumab for COPD with allergies
This trial tests if omalizumab, an allergy medication, can help people with COPD who have allergies to common indoor triggers like cat, dog, mouse, cockroach, or dust mite. It aims to reduce flare-ups and improve breathing.
Birmingham, AlabamaAges 40 years+ - NCT07110311Recruiting
How pet cats affect nose and gut bacteria in cat allergy patients
This study looks at how living with a pet cat might affect the bacteria in your nose and gut if you have dust mite and cat allergies. It could help us understand if cats actually change your allergy symptoms or the balance of bugs in your body.
Nanjing, JiangsuAges 18–65 - NCT07117669RecruitingPhase 1/Phase 2
Testing a new peanut allergy treatment (ENP-501)
This trial tests a new peanut allergy treatment called ENP-501. It aims to see if the medicine can safely help people with peanut allergy become less sensitive to peanuts.
Aurora, ColoradoAges 14–50 - NCT07169318RecruitingPhase 1
Safety study of VNT-101 in healthy adults
This first-in-human study tests the safety of a new medicine called VNT-101. Healthy adults aged 18 to 59 who do not smoke and have no major health problems may be able to join. The goal is to see how the body handles the drug and if it is safe.
Overland Park, KansasAges 18–59 - NCT07202598RecruitingPhase 2
Testing emapalumab for gut inflammation in APECED
This trial tests a drug called emapalumab to treat chronic gut inflammation (enteritis) in people with APECED, a rare immune disorder. It aims to see if the drug can help when other treatments haven't worked.
Bethesda, MarylandAges 2–75 - NCT07212530Recruiting
EmoTIChealth: A game to boost teen health
This trial tests a serious video game designed to help teenagers learn skills for better health. It's for 12- to 16-year-olds who speak Spanish and have internet access.
Valencia, ValenciaAges 12–16 - NCT06504160RecruitingPhase 1
Testing a bacteria cream for eczema (TIME-2)
This study tests whether a cream made from a friendly skin bacteria (Staphylococcus hominis) can help treat eczema. Eligible participants will apply the cream to eczema patches on their arms, legs, or trunk for several weeks.
San Diego, CaliforniaAges 6 years+ - NCT07288827Recruiting
Study of airway sensitivity in primary ciliary dyskinesia
This study looks at how the airways in people with primary ciliary dyskinesia (PCD) react to certain triggers. It aims to understand if these airways are more sensitive, which could help improve treatment for breathing problems.
Indianapolis, IndianaAges 6 years+ - NCT07321522Recruiting
Early feeding of allergenic foods in infants
This study tests whether introducing common allergenic foods early and continuing them for six months can help prevent food allergies in infants. It is for babies who have not yet started these foods.
Stanford, CaliforniaAges 4 months–11 months - NCT07342491RecruitingPhase 1
Testing dasatinib to shrink HIV reservoir
This trial tests whether the drug dasatinib can reduce the hidden HIV reservoir in people who have had their virus well-controlled on HIV medications for a long time. It may help move toward a cure by targeting the cells where HIV hides.
Chicago, IllinoisAges 18 years+ - NCT06136091Recruiting
Asthma study in select communities using a smartphone app
This study looks at how asthma affects people in certain communities and tests a new way to manage it using a smartphone app. It is for people with long-standing asthma and those without asthma, to compare their health over time.
Aurora, ColoradoAges 6–17 - NCT00018044Recruiting
Understanding Immune Defects in Mycobacterial Infections
This research study aims to better understand why some people develop unusual bacterial infections (mycobacterial infections) that don't respond well to standard treatments. Researchers will examine your immune system and may study family members to identify genetic factors that increase infection risk.
Bethesda, MarylandAges Up to 100 years - NCT00267501Recruiting
Study collects data and samples to understand eosinophilic conditions
This study collects information and biological samples to better understand what causes certain allergic/eosinophilic conditions. It may help researchers learn mechanisms and improve future care.
Cincinnati, OhioAges Any age - NCT01386424Recruiting
Healthy adult check-in for future infectious-disease volunteer studies
This study enrolls healthy adults to help set up future research studies about infectious diseases. If you qualify, you may be asked to join later “healthy volunteer” experiments and allow your samples to be stored for future research.
Bethesda, MarylandAges 18–65
Hear when a new Allergy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for allergy?
- Yes. Clin2 currently lists 323 recruiting allergy studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a allergy trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a allergy trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.